M&A Deal Summary |
|
|---|---|
| Date | 2025-01-22 |
| Target | ImaginAb - Therapeutic Pipeline |
| Sector | Life Science |
| Buyer(s) | Telix Pharmaceuticals |
| Sellers(s) | ImaginAb |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Telix Pharmaceuticals Ltd. is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector (Life Science) | 6 of 6 |
| Type (Divestiture) | 3 of 3 |
| State (California) | 2 of 2 |
| Country (United States) | 5 of 5 |
| Year (2025) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-23 |
RLS Radiopharmacies
Lake Mary, Florida, United States RLS Radiopharmacies is a General Electric Channel Partner engaged in isotope production and delivery of service to the nuclear medicine market. RLS Radiopharmacies is based in Lake Mary, Florida. |
Buy | $230M |
ImaginAb is a clinical-stage, revenue-generating global biotechnology company developing the next generation of radiopharmaceutical and imaging agent products. ImaginAb was formed in 2007 and is headquartered in Inglewood, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2025) | 1 of 1 |
